Bioplatforms Australia drives cancer cures across the nation
Australia is a global leader in cancer genomics research and translation, driving improved survival rates in children and adults. Bioplatforms Australia provides national genomics and bioinformatics infrastructure supporting collaborative programs that convert genomic data into actionable clinical insights across melanoma, paediatric and adult cancers, including the following national initiatives: The Australian Melanoma Genome Project, co-led […]
Australian National Fabrication Facility (ANFF)
ANFF owns and provides access to micro and nanofabrication capabilities for Australia’s researchers and industry. We can assist in both the development of new products and improvements to current production methods. Each Node provides expertise in a specific area, including advanced materials, nanoelectronics & photonics and nano-bio applications. The ANFF commitment to providing a world-class, open-access user facility is underpinned by the sharing of best practice in service provision across the network.
The unseen engine
How Australia’s investment in research and infrastructure is forging global quantum leadership Over the past 20 years, Australia has quietly secured a position at the forefront of the quantum revolution. Not only are we building some of the world’s first commercial quantum computers but quantum science is being employed in a new generation of sensors, […]
Pawsey Supercomputing Research Centre (Pawsey)
Pawsey Supercomputing Research Centre is home of Setonix, Australia’s fastest and most energy-efficient supercomputer, delivering the nation’s most advanced AI research infrastructure through massive GPU power.
Our integrated platform combines cutting-edge GPU acceleration with AI frameworks, real-time analytics, and advanced remote visualisation services and expertise. This gives researchers nationwide access to the scale, speed and expertise needed to accelerate discovery and innovation across every field, from climate modelling and drug discovery to quantum research and astronomy.
Phenomics Australia (PA)
Phenomics Australia provides a national capability to explore the human genome and the genetic basis of health and disease. Our openly accessible service delivery centres span twenty locations across Australia. Through these, we offer specialised infrastructure, research services and technical expertise dedicated to advancing our fundamental understanding of health and disease and enabling next-generation innovations in healthcare and therapeutic development to benefit all Australians.
AARNet
AARNet is Australia’s national research and education network, a not-for-profit organisation equally owned by 38 Australian universities and CSIRO. AARNet provides essential high-speed internet and advanced network services tailored to meet the specialised needs of researchers in Australia.
EMBL Australia PhD Course celebrates 10 years of training Australia’s future research leaders
More than 60 PhD students from across the country came together in Adelaide for the 10th EMBL Australia PhD Course – a unique, two-week residential program designed to equip emerging researchers with the skills and confidence needed for modern scientific careers. Co-hosted with the South Australian Immunogenomics Cancer Institute (SAiGENCI), this year’s course focused on future-ready […]
Strengthening international research relations and showcasing Australian capability
Driving global collaboration through the Prato 2025 Health Research Infrastructure Symposium The 2025 Australian & European Health Research Infrastructure Symposium, held from 16-18 September at the Monash University Prato Centre in Italy, united leaders from major Australian and European research infrastructures to strengthen international partnerships and tackle shared challenges in health and life sciences. The three-day […]
Cost-effective imaging technology to revolutionise spatial transcriptomics
EMBL Australia group leader Dr William Roman & his team have launched a new imaging-based spatial transcriptomics platform that dramatically reduces experimental costs from more than $35,000 to approximately $30 per experiment, making spatial biology more accessible to researchers across Australia. While modern sequencing technology has made it relatively easy to tell which genes are […]
MAB: advancing bioimaging through collaboration and innovation
EMBL Australia Group Leader Dr Senthil Arumugam, along with Dr Toby Bell and Dr Kate McArthur, recently launched the Monash BDI Advanced Bioimaging (MAB) platform – a researcher-led, global collaboration hub designed to bring innovative microscopy technologies directly to the researchers who need them. From light-sheet imaging to custom-built microscopes and large-scale data visualisation, MAB integrates experimental […]
Powerful software reveals brain superhighway ‘tracts’ for surgery and research
Our brains work a bit like highly advanced supercomputers, with bundles of white matter, known as ‘tracts,’ acting as superhighways that facilitate information flow and enable various brain functions. Injuries and disturbances in these tracts are linked to numerous neurological and psychiatric disorders. However, imaging these white matter tracts is challenging. These tracts are made […]
First in-human images of new hope treatment for poor-prognosis prostate cancer
In a world first, supported by National Imaging Facility, Australian researchers have imaged and measured the uptake of a promising new prostate cancer therapy drug developed by Australian company AdvanCell, which was recently administered to its first patient in a clinical trial. Prostate cancer is the second most common cancer for men. Around 50% of […]
New brain imaging set to improve and speed epilepsy diagnosis, treatment
Novel imaging methods combined with cognitive, genetic and medical data will use AI to increase the speed and accuracy of diagnoses and treatment for epilepsy patients, according to researchers working collaboratively with NIF. Advanced MRI imaging methods are helping Australian epilepsy researchers move closer to faster, more accurate, individualised diagnoses and treatment options for patients. […]
Future-proofing computational proteomics
EMBL Australia and Bioplatforms Australia joined forces to host a pivotal proteomics workshop titled ‘Future-proofing Computational Proteomics’ on 24 April, featuring leading guest speakers, Dr Rolf Apweiler, Prof Marc Wilkins and Dr Richard Lipscombe. The Australian proteomics community discussed advancements in proteomics research and the pivotal role of computational approaches in shaping the future of […]
Australian health research infrastructure underpins world-first brain cancer collaboration
The NCRIS Health Group will support Australian brain cancer research through Brain Cancer Australia’s project to develop an integrated network of research platforms to improve patient outcomes, test new treatments and work toward a cure, with the announcement of a Medical Research Future Fund (MRFF) grant worth just under $6M. The project brings together clinicians, […]
Protein discovery for better bowel cancer treatments
Bowel cancer claims more than 100 lives in Australia every week. Thankfully, researchers at the Australian National University (ANU) have discovered that an immune protein can slow the division of bowel cancer cells. This is a promising target for both early detection tests and bowel cancer treatments. DR ABHIMANU PANDEY SAYS AN IMMUNE SYSTEM PROTEIN […]
Strengthening our European connections to EMBL and beyond
On a recent visit to EMBL Heidelberg, Ian Smith, Chair of the EMBL Australia Council, spoke about the synergies between EMBL and EMBL Australia, opportunities for collaboration and ideas for exciting future programs. Ian Smith, Chair of the EMBL Australia Council, chatted to EMBL about the synergies between the organisations, opportunities for collaboration, and ideas […]
Vaccine patch delivers protection from dengue in mice
Dengue is the most significant mosquito-borne viral disease in the world. With an estimated 390 million cases annually, it results in approximately US$6.9 billion in economic losses. Now Dr David Muller and the vaccine team at the University of Queensland (UQ) have developed a promising dengue vaccine candidate that provides strong immunity in mice when […]
Biobanks: the Australian Phenome Bank
The Australian Phenome Bank: a national biobank and database aiding the discovery of genetic disease causes and advancing Personalised Medicine. Phenomics Australia’s Biobanking service provides a database and cryobank of mouse sperm and embryos essential for discovering and distributing disease models in Australia. The challenge: Ensuring the ongoing availability of mouse strains preserving the investment made in […]
CRISPR/Cas as diagnostics tools
Phenomics Australia NCRIS expertise is used in providing knowledge to look into the commercial and translational potential of CRISPR technology. Phenomics Australia’s long-term support of the In vivo Genome Engineering and Disease Modelling nodes over the years has allowed researchers at the Melbourne Advanced Genome Editing Center (MAGEC) to have a solid understanding of CRISPR/Cas […]
When food kills
Infrastructure and expertise supported by Phenomics Australia and Therapeutic Innovation Australia (TIA)are used in fighting food poisoning toxins. Prof Si Ming Man (right) and Dr Anukriti Mathur (left). Image Lannon Harley/ANU The challenge: Food poisoning is estimated to affect more than 4 million Australians every year – costing the economy $1.25 billion, and in some […]
WearOptimo create real-time, Microwearable health sensors
WearOptimo have used Microscopy Australia’s facilities to develop a world-first, wearable, real-time health sensor, which is now in clinical trials. WearOptimo aims to provide affordable, wearable technology to revolutionise monitoring of biomarkers, which act as an early warning sign of disease. Initially, their sticker like device will provide real time monitoring of hydration and of heart […]
How Australia’s national research infrastructure is responding to COVID-19
Australia’s National Research Infrastructure (NRI) swiftly redeployed to support national and international COVID-19 research. Some examples are listed below. Australian Centre for Disease Preparedness (ACDP), Bioplatforms Australia (BPA), Microscopy Australia and Therapautic Innovation Australia (TIA) were involved in the University of Queensland vaccine program. Australian Plant Phenomics Facility (APPF) is supporting research into plant-based vaccines. Astronomy Australia […]
Nano-thin piezoelectrics advance self-powered electronics
A new type of ultra-efficient, nano-thin material could advance self-powered electronics, wearable technologies and even deliver pacemakers powered by heart beats. The flexible and printable piezoelectric material, which can convert mechanical pressure into electrical energy, has been developed by an Australian research team led by RMIT University. It is 100,000 times thinner than a human […]
New Era in X-Ray Imaging
Next generation X-ray technology, developed and manufactured in Adelaide, is solving global health, defence and security challenges by making X-ray machines significantly lighter and more portable. In-depth imaging is now available on the move thanks to Adelaide-based medical device manufacturer, Micro-X, which has commercialised a new way of producing x-rays. The ASX-listed company is harnessing […]
Elastagen – Skinnovation in treatment for burns victims
Elastagen Pty Ltd is a clinical stage medical device company that is pioneering Elastatherapy™ using the human protein elastin to naturally repair and augment the skin. The company has arisen out of patented research conducted by Prof. Tony Weiss’s group at the University of Sydney and their first clinical trials have demonstrated the biocompatability and […]
